Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMetals Exploration Regulatory News (MTL)

Share Price Information for Metals Exploration (MTL)

Share Price is delayed by 15 minutes
Get Live Data
13.15    0.00 (0.00%)
Bid:
13.00
Ask:
13.30
Spread: 0.30 (2.308%)
Market Cap: £393.37m
MTL Live PriceLast checked at - London Stock Exchange

Intraday Metals Exploration Share Chart

Runruno Scoping Study Update

15 Jul 2008 07:00

RNS Number : 0459Z
Metals Exploration PLC
15 July 2008
 



Metals Exploration PLC

Runruno Scoping Study - Update

BIOX® selected as preferred process route

15 July 2008

Metals Exploration PLC ('Metals Ex' or 'the Company'), the natural resources exploration and development Company with assets in the Pacific Rim region, is pleased to provide an update on the progress of the Scoping Study being conducted on its Runruno gold-molybdenum deposit in the Philippines.

Highlights:

BIOX® technology selected as the preferred processing technology following a detailed assessment of the gold and potential molybdenum recovery and the likely capital and operating costs. 

Ausenco well advanced in process design and capital and operating cost estimation.

Diamond and RC drilling completed for this stage.

Design and costing of infrastructure components proceeding well with no fatal flaws identified.

Study expected to be finalised in late August - early September

Processing 

BIOX® processing technology has been selected as the preferred technology to be used in the oxidisation circuit for processing ore at Runruno.

Both BIOX® and Pressure Oxidation (POX) technologies have been shown by test-work to be equally applicable to processing Runruno ores with excellent gold recovery and good dissolution of molybdenum. In order to assess the application of the technologies to Runruno and to provide a basis for selecting a preferred processing route, the Company commissioned Gold Fields Mining Services to undertake a study on the capital (Capex) and operating (Opex) costs and the benefits and disadvantages of the BIOX® technology. Similarly, a study of the POX technology was undertaken by Ausenco.

The results of these comparative studies have shown that the Capex and Opex cost regime estimated for BIOX® technology is significantly lower than that estimated for POX; with BIOX® Capex estimated at about 50% and Opex at about 66% of that estimated for POX. Analysis of the benefits and disadvantages of the two technologies has shown BIOX® to be of a lower operating risk and more suited to the application proposed.

As a direct consequence of the finalisation of the gold processing route, molybdenum recovery test-work will now be focussed on a chemical recovery process rather than a physical process such as recovery into a saleable flotation concentrate. To date, BIOX® test-work has been encouraging with up to 78% of the molybdenum contained in concentrate being dissolved during oxidation. When combined with recoveries into the flotation concentrate, the Company is targeting overall molybdenum recoveries of around 50%, implying annual production of approximately 2 mlbs Mo per annum.

The ongoing test-work program will now focus on the recovery of the molybdenum from solution and the optimisation of the dissolution of the molybdenum. Work has commenced on this program.

Process Design

Ausenco is well advanced with process design and the Capex and Opex estimates for the processing plant. The metallurgical circuit and layout is proving to be relatively straightforward, and now that BIOX® has been chosen as the preferred process route the circuit is likely to share a number of similarities with Sino Gold's Jinfeng mine in China.

It is expected that this component of the study will be completed during August.

Resource Drilling

The drilling program designed to support the Scoping Study is now complete. All of the holes have been sampled and submitted for assay with about half returned to date. The majority of the holes completed were in-fill holes designed to add certainty to the resource estimate. 

Once all the assay data has been received and the geological interpretation and model confirmed the mineral resource will be re-estimated. Subject to receipt of assay data the resource update should be available by the end of August. This updated resource will then be used as a base to finalise mine planning.

Drilling using three diamond drill rigs is continuing on the boundaries of the resource.

Infrastructure

Infrastructure studies are proceeding well with no fatal flaws identified. Parsons Brinkerhoff and GHD along with a number of other Philippine based specialists have been retained by the Company to assist with these works.

Scoping Study

The Scoping Study is proceeding satisfactorily after some delays caused by the unsatisfactory performance of the drilling contractor during the early stages of the program and the widespread shortage of senior experienced technical resources endemic in the industry. Both these issues have been successfully addressed.

It is now expected that the study will be finalised late in August - or early September.

Jonathan Beardsworth, Chief Executive of Metals Ex, said: 

"It is pleasing to be able to report that the Scoping Study is making such good progress across a range of disciplines - in-fill drilling, resource update, mineplanning, selection of process route, likely moly recoveries, and infrastructure studies.

Our confidence in the resource and the likelihood of being able to develop a mine at Runruno grows with every report received"

For more information:

 

Jonathan Beardsworth + 44 (0) 20 7927 6690

CEO + 44 (0) 7747 101 552Tim Feather +44 (0) 20 7601 6100

Hanson Westhouse

Charles Vivian + 44 (0) 20 7743 6672Pelham PR

Klara Kaczmarek + 44 (0) 20 3159 4395Pelham PR

QUALIFIED/COMPETENT PERSONS

Mr Ian Holzberger, who is the Project Director for the development of the Runruno Project and a Director of the Company, has been involved in the mining and exploration industry for more than 35 years. He has compiled, read and approved the technical disclosure in this regulatory announcement.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBLGDRCXBGGIS
Date   Source Headline
1st May 20207:00 amRNSQuarterly Update To 31 March 2020
27th Apr 202012:01 pmRNSUpdated Mineral Reserve Estimate
26th Mar 20207:00 amRNSOperational Update
9th Mar 20207:30 amRNSSuspension - Metals Exploration plc
9th Mar 20207:00 amRNSUpdate on Senior Facility & Suspension of Trading
19th Feb 20202:00 pmRNSQuarterly Update to 31 December 2019
31st Jan 20207:00 amRNSSale of Senior Facility Completed
22nd Jan 20207:00 amRNSFunding and Banking Update
15th Nov 20197:00 amRNSQuarterly Update To 30 September 2019
13th Sep 20197:00 amRNSHalf-year Report
8th Aug 20194:20 pmRNSQuarterly Update To 30 June 2019
1st Aug 20197:00 amRNSFunding and Banking Update
28th Jun 20193:11 pmRNSFunding and Banking Update
25th Jun 20196:02 pmRNSResults of AGM
25th Jun 20197:00 amRNSAGM Statement
3rd Jun 20197:00 amRNSFunding and Banking Update
30th May 201910:00 amRNSPosting of Annual Report and Notice of AGM
30th May 20197:06 amRNSFinal Results For The Year Ended 31 December 2018
3rd May 20197:00 amRNSFunding and Banking Update
24th Apr 20197:00 amRNSQuarterly Update To 31 March 2019
12th Apr 20197:00 amRNSAppointment of Nominated Adviser
1st Apr 20197:00 amRNSFunding and Banking Update
29th Mar 20191:25 pmRNSFunding and Banking Update
15th Mar 20197:00 amRNSResignation of Nominated Adviser
12th Mar 201910:15 amRNSFunding & Banking Update-Debt Standstill Requested
7th Mar 201911:00 amRNSPrice Monitoring Extension
7th Mar 20199:05 amRNSSecond Price Monitoring Extn
7th Mar 20199:00 amRNSPrice Monitoring Extension
6th Mar 20193:58 pmRNSFunding and Banking Update
28th Feb 20197:00 amRNSInterim CFO Appointed
27th Feb 20197:00 amRNSResults of Operational Review and Clarifications
18th Feb 201912:35 pmRNSAmendment to Senior Lenders' Facility Agreement
8th Feb 201911:14 amRNSBanking Update - Replacement
8th Feb 201910:08 amRNSBanking Update
5th Feb 201910:51 amRNSAppointment of Non-Executive Director
31st Jan 20194:46 pmRNSBanking Update
30th Jan 20199:23 amRNSQuarterly Update To 31 December 2018
28th Jan 20197:00 amRNSHolding(s) in Company
25th Jan 20193:22 pmRNSDirectorship Change
25th Jan 20199:23 amRNSAppointment of Chairman
24th Jan 201912:09 pmRNSDirectorate Change
16th Jan 20198:36 amRNSCorporate Update
4th Jan 201910:11 amRNSShort Term Loans Update
3rd Jan 20197:14 amRNSAppointment of Darren Bowden as CEO
31st Dec 201810:15 amRNSShort Term Loans Update
6th Dec 201812:07 pmRNSDirectorate Change
22nd Nov 20187:00 amRNSWorking Capital Funding
5th Nov 201812:38 pmRNSBanking Update
2nd Nov 201810:11 amRNSOperations Update
25th Oct 20189:31 amRNSQuarterly Update to 30 September 2018

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.